These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Does co-administration of a non-selective opiate antagonist enhance acceleration of transit by a 5-HT4 agonist in constipation-predominant irritable bowel syndrome? A randomized controlled trial. Foxx-Orenstein AE; Camilleri M; Szarka LA; McKinzie S; Burton D; Thomforde G; Baxter K; Zinsmeister AR Neurogastroenterol Motil; 2007 Oct; 19(10):821-30. PubMed ID: 17539894 [TBL] [Abstract][Full Text] [Related]
23. Effects of bisacodyl on ascending colon emptying and overall colonic transit in healthy volunteers. Manabe N; Cremonini F; Camilleri M; Sandborn WJ; Burton DD Aliment Pharmacol Ther; 2009 Nov; 30(9):930-6. PubMed ID: 19678812 [TBL] [Abstract][Full Text] [Related]
24. A randomised, placebo-controlled trial comparing the effects of tapentadol and oxycodone on gastrointestinal and colonic transit in healthy humans. Jeong ID; Camilleri M; Shin A; Iturrino J; Boldingh A; Busciglio I; Burton D; Ryks M; Rhoten D; Zinsmeister AR Aliment Pharmacol Ther; 2012 May; 35(9):1088-96. PubMed ID: 22348605 [TBL] [Abstract][Full Text] [Related]
25. Clinical pharmacodynamics of SDZ HTF 919, a new 5-HT4 receptor agonist, in a model of slow colonic transit. Appel S; Kumle A; Meier R Clin Pharmacol Ther; 1997 Nov; 62(5):546-55. PubMed ID: 9390111 [TBL] [Abstract][Full Text] [Related]
26. The effects of methylnaltrexone alone and in combination with acutely administered codeine on gastrointestinal and colonic transit in health. Wong BS; Rao AS; Camilleri M; Manabe N; McKinzie S; Busciglio I; Burton DD; Ryks M; Zinsmeister AR Aliment Pharmacol Ther; 2010 Oct; 32(7):884-93. PubMed ID: 20839388 [TBL] [Abstract][Full Text] [Related]
27. Randomised clinical trial: the effects of daikenchuto, TU-100, on gastrointestinal and colonic transit, anorectal and bowel function in female patients with functional constipation. Iturrino J; Camilleri M; Wong BS; Linker Nord SJ; Burton D; Zinsmeister AR Aliment Pharmacol Ther; 2013 Apr; 37(8):776-85. PubMed ID: 23451764 [TBL] [Abstract][Full Text] [Related]
28. Effect of alvimopan and codeine on gastrointestinal transit: a randomized controlled study. Gonenne J; Camilleri M; Ferber I; Burton D; Baxter K; Keyashian K; Foss J; Wallin B; Du W; Zinsmeister AR Clin Gastroenterol Hepatol; 2005 Aug; 3(8):784-91. PubMed ID: 16234007 [TBL] [Abstract][Full Text] [Related]
29. Dose-response effect of a beta3-adrenergic receptor agonist, solabegron, on gastrointestinal transit, bowel function, and somatostatin levels in health. Grudell AB; Camilleri M; Jensen KL; Foxx-Orenstein AE; Burton DD; Ryks MD; Baxter KL; Cox DS; Dukes GE; Kelleher DL; Zinsmeister AR Am J Physiol Gastrointest Liver Physiol; 2008 May; 294(5):G1114-9. PubMed ID: 18372395 [TBL] [Abstract][Full Text] [Related]
30. Chenodeoxycholate in females with irritable bowel syndrome-constipation: a pharmacodynamic and pharmacogenetic analysis. Rao AS; Wong BS; Camilleri M; Odunsi-Shiyanbade ST; McKinzie S; Ryks M; Burton D; Carlson P; Lamsam J; Singh R; Zinsmeister AR Gastroenterology; 2010 Nov; 139(5):1549-58, 1558.e1. PubMed ID: 20691689 [TBL] [Abstract][Full Text] [Related]
31. Effect of tegaserod on gut transit in male and female subjects. Degen L; Petrig C; Studer D; Schroller S; Beglinger C Neurogastroenterol Motil; 2005 Dec; 17(6):821-6. PubMed ID: 16336497 [TBL] [Abstract][Full Text] [Related]
32. Abnormalities of GI transit in bloated irritable bowel syndrome: effect of bran on transit and symptoms. Hebden JM; Blackshaw E; D'Amato M; Perkins AC; Spiller RC Am J Gastroenterol; 2002 Sep; 97(9):2315-20. PubMed ID: 12358250 [TBL] [Abstract][Full Text] [Related]
33. Comparison of selective M3 and nonselective muscarinic receptor antagonists on gastrointestinal transit and bowel habits in humans. Bharucha AE; Ravi K; Zinsmeister AR Am J Physiol Gastrointest Liver Physiol; 2010 Jul; 299(1):G215-9. PubMed ID: 20395537 [TBL] [Abstract][Full Text] [Related]
34. Digestion-resistant maltodextrin effects on colonic transit time and stool weight: a randomized controlled clinical study. Abellán Ruiz MS; Barnuevo Espinosa MD; Contreras Fernández CJ; Luque Rubia AJ; Sánchez Ayllón F; Aldeguer García M; García Santamaría C; López Román FJ Eur J Nutr; 2016 Dec; 55(8):2389-2397. PubMed ID: 26437831 [TBL] [Abstract][Full Text] [Related]
35. Effect of a novel 5-HT3 receptor agonist MKC-733 on upper gastrointestinal motility in humans. Coleman NS; Marciani L; Blackshaw E; Wright J; Parker M; Yano T; Yamazaki S; Chan PQ; Wilde K; Gowland PA; Perkins AC; Spiller RC Aliment Pharmacol Ther; 2003 Nov; 18(10):1039-48. PubMed ID: 14616171 [TBL] [Abstract][Full Text] [Related]
36. Effects of chenodeoxycholate and a bile acid sequestrant, colesevelam, on intestinal transit and bowel function. Odunsi-Shiyanbade ST; Camilleri M; McKinzie S; Burton D; Carlson P; Busciglio IA; Lamsam J; Singh R; Zinsmeister AR Clin Gastroenterol Hepatol; 2010 Feb; 8(2):159-65. PubMed ID: 19879973 [TBL] [Abstract][Full Text] [Related]
37. Effect of cyclooxygenase-2 inhibitors on gastric emptying and small intestinal transit in humans. Bouras EP; Burton DD; Camilleri M; Stephens DA; Thomforde GM Neurogastroenterol Motil; 2004 Dec; 16(6):729-35. PubMed ID: 15601422 [TBL] [Abstract][Full Text] [Related]
38. Effect of female sex hormone supplementation and withdrawal on gastrointestinal and colonic transit in postmenopausal women. Gonenne J; Esfandyari T; Camilleri M; Burton DD; Stephens DA; Baxter KL; Zinsmeister AR; Bharucha AE Neurogastroenterol Motil; 2006 Oct; 18(10):911-8. PubMed ID: 16961694 [TBL] [Abstract][Full Text] [Related]